Santhera Pharmaceuticals
SANN.SW
#8187
Rank
HK$1.46 B
Marketcap
HK$116.08
Share price
-10.20%
Change (1 day)
40.81%
Change (1 year)

EPS for Santhera Pharmaceuticals (SANN.SW)

EPS in 2018 (TTM): -HK$291.11

According to Santhera Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$98.21. In 2022 the company made an earnings per share (EPS) of -HK$98.21 an increase over its 2021 EPS that were of -HK$137.84.

EPS history for Santhera Pharmaceuticals from 2006 to 2018

Annual EPS

Year EPS Change
2022-HK$98.21-28.75%
2021-HK$137.84-69.23%
2020-HK$448.00222.64%
2019-HK$138.85-77.65%
2018-HK$621.26-5.34%
2017-HK$656.3152.2%
2016-HK$431.20-593.67%
2015HK$87.35-165.72%
2014-HK$132.91-2.15%
2013-HK$135.83-81.35%
2012-HK$728.3815.64%
2011-HK$629.85145.81%
2010-HK$256.24-53.37%
2009-HK$549.52-152.24%
2008HK$1,052-270.36%
2007-HK$617.43-33.09%
2006-HK$922.77